Reuters logo
BRIEF-Cardiome's partner SteadyMed receives favorable ruling in its USPTO Inter Partes review
April 3, 2017 / 12:24 PM / 8 months ago

BRIEF-Cardiome's partner SteadyMed receives favorable ruling in its USPTO Inter Partes review

April 3 (Reuters) - Cardiome Pharma Corp:

* Cardiome’s partner SteadyMed receives favorable ruling in its USPTO Inter Partes review

* Cardiome Pharma Corp says in its ruling, PTAB found all 22 claims of ‘393 patent were unpatentable

* Cardiome Pharma Corp says Cardiome currently expects to file for European Medicines Agency (EMA) approval of Trevyent during 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below